BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 36243280)

  • 41. The role of CD4 cell count as discriminatory measure to guide chemoprophylaxis against Pneumocystis jirovecii pneumonia in human immunodeficiency virus-negative immunocompromised patients: A systematic review.
    Messiaen PE; Cuyx S; Dejagere T; van der Hilst JC
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28035717
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Low-Dose vs Conventional-Dose Trimethoprim-Sulfamethoxazole Treatment for Pneumocystis Pneumonia in Patients Not Infected With HIV: A Multicenter, Retrospective Observational Cohort Study.
    Nagai T; Matsui H; Fujioka H; Homma Y; Otsuki A; Ito H; Ohmura S; Miyamoto T; Shichi D; Tomohisa W; Otsuka Y; Nakashima K
    Chest; 2024 Jan; 165(1):58-67. PubMed ID: 37574166
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment With Reduced-Dose Trimethoprim-Sulfamethoxazole Is Effective in Mild to Moderate Pneumocystis jirovecii Pneumonia in Patients With Hematologic Malignancies.
    Hammarström H; Krifors A; Athlin S; Friman V; Golestani K; Hällgren A; Otto G; Oweling S; Pauksens K; Kinch A; Blennow O
    Clin Infect Dis; 2023 Feb; 76(3):e1252-e1260. PubMed ID: 35594562
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged, non-high-dose steroids-clinical implication of primary prophylaxis using trimethoprim-sulfamethoxazole.
    Park JW; Curtis JR; Kim MJ; Lee H; Song YW; Lee EB
    Arthritis Res Ther; 2019 Sep; 21(1):207. PubMed ID: 31521185
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort.
    Neofytos D; Hirzel C; Boely E; Lecompte T; Khanna N; Mueller NJ; Boggian K; Cusini A; Manuel O; van Delden C;
    Transpl Infect Dis; 2018 Dec; 20(6):e12984. PubMed ID: 30155950
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Higher risk of urinary tract infections in renal transplant recipients receiving pentamidine versus trimethoprim-sulfamethoxazole (TMP-SMX) for Pneumocystis pneumonia prophylaxis.
    Fu W; Barahona M; Harkness T; Cohen E; Reardon D; Yoo PS
    Clin Transplant; 2020 Nov; 34(11):e14067. PubMed ID: 32810885
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pneumocystis jirovecii pneumonia in kidney transplantation.
    Goto N; Oka S
    Transpl Infect Dis; 2011 Dec; 13(6):551-8. PubMed ID: 22093172
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pneumocystis jirovecii Pneumonia in the Non-HIV-Infected Population.
    Avino LJ; Naylor SM; Roecker AM
    Ann Pharmacother; 2016 Aug; 50(8):673-9. PubMed ID: 27242349
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of Low-Dose Trimethoprim/Sulfamethoxazole for the Treatment of
    Ji J; Wang Q; Huang T; Wang Z; He P; Guo C; Xu W; Cao Y; Dong Z; Wang H
    Infect Drug Resist; 2021; 14():4913-4920. PubMed ID: 34853519
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pneumocystis jirovecii pneumonia prophylaxis in allogeneic hematopoietic cell transplant recipients: can we always follow the guidelines?
    Redjoul R; Robin C; Foulet F; Leclerc M; Beckerich F; Cabanne L; di Blasi R; Pautas C; Toma A; Botterel F; Maury S; Cordonnier C
    Bone Marrow Transplant; 2019 Jul; 54(7):1082-1088. PubMed ID: 30413810
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Benefits of sulfamethoxazole-trimethoprim prophylaxis on rates of sepsis after kidney transplant.
    Horwedel TA; Bowman LJ; Saab G; Brennan DC
    Transpl Infect Dis; 2014 Apr; 16(2):261-9. PubMed ID: 24621104
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The efficacy and safety of reduced-dose sulfamethoxazole-trimethoprim for chemoprophylaxis of
    Harada T; Kato R; Sueda Y; Funaki Y; Takata M; Okazaki R; Hasegawa Y; Yamasaki A
    Mod Rheumatol; 2021 May; 31(3):629-635. PubMed ID: 32820678
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Low-Dose TMP-SMX in the Treatment of
    Butler-Laporte G; Smyth E; Amar-Zifkin A; Cheng MP; McDonald EG; Lee TC
    Open Forum Infect Dis; 2020 May; 7(5):ofaa112. PubMed ID: 32391402
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pneumocystis jirovecii Pneumonia Prophylaxis with Intravenous Pentamidine in Adult Allogeneic Hematopoietic Stem Cell Transplant Patients.
    McCollam S; Lewis JS; Bubalo J; Diaz A
    Antimicrob Agents Chemother; 2022 Nov; 66(11):e0083322. PubMed ID: 36214573
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy and Safety of Dapsone Versus Trimethoprim/Sulfamethoxazol for Pneumocystis Jiroveci Prophylaxis in Children With Acute Lymphoblastic Leukemia With a Background of Ethnic Neutropenia.
    Nazir HF; Elshinawy M; AlRawas A; Khater D; Zadjaly S; Wali Y
    J Pediatr Hematol Oncol; 2017 Apr; 39(3):203-208. PubMed ID: 28234744
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Trimethoprim-Sulfamethoxazole-associated early neutropenia in Mexican adults living with HIV: A cohort study.
    Jacobo-Vargas TB; Báez-Saldaña R; Cruz-Hervert LP; Fortoul TI; Ahumada-Topete VH; Rodríguez-Ganén O; Vega-Barrientos RS
    PLoS One; 2023; 18(5):e0285541. PubMed ID: 37167312
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Trimethoprim-sulphamethoxazole appears more effective than aerosolized pentamidine as secondary prophylaxis against Pneumocystis carinii pneumonia in patients with AIDS.
    Carr A; Tindall B; Penny R; Cooper DA
    AIDS; 1992 Feb; 6(2):165-71. PubMed ID: 1558714
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of Increased Duration of Trimethoprim-Sulfamethoxazole Prophylaxis for Pneumocystis Pneumonia After Renal Transplant.
    Chapman FA; Dickerson JE; Daly C; Clancy M; Geddes C
    Ann Transplant; 2019 Dec; 24():625-630. PubMed ID: 31806862
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Atovaquone versus trimethoprim-sulfamethoxazole as Pneumocystis jirovecii pneumonia prophylaxis following renal transplantation.
    Gabardi S; Millen P; Hurwitz S; Martin S; Roberts K; Chandraker A
    Clin Transplant; 2012; 26(3):E184-90. PubMed ID: 22487221
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Twice weekly Pneumocystis jiroveci pneumonia prophylaxis with trimethoprim-sulfamethoxazole in pediatric patients with acute lymphoblastic leukemia.
    Agrawal AK; Chang PP; Feusner J
    J Pediatr Hematol Oncol; 2011 Jan; 33(1):e1-4. PubMed ID: 21102354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.